It is with great pleasure that we invite you to participate in the ESMO Deep Dive Webinar on biliary tract cancers, elaborating the facts from molecule to medicine.
This webinar is developed with the aim to understand the pathogenesis of biliary tract cancers and how underlying liver disease contributes to the development of these cancers and may inform treatment, as well as to describe mutations and other genetic alterations that inform the current use of both targeted and immune-based therapies in biliary tract cancers, and to learn about emerging biomarkers that hold promise for novel drug developments in the biliary tract cancers.
We will begin with a lecture on implications of aetiology, underlining liver disease and chronic inflammatory disorders in biliary tract cancers. This will follow with elaboration of implications of molecular subgroups for precision cancer medicine. Finally, we will provide an overview of implications of molecular subgroups for immune-based therapy. The lectures will be followed by a live discussion with the speakers’ panel.
This programme is designed to provide an overview of the latest understanding of molecular biology and the impact of targeting different pathways in the management of patients with biliary tract cancers, offer expert opinion exchange and provide some important considerations in this field. We strongly encourage and invite you to register and join us all in this new ESMO activity.
Prof. Andrew Ko
University of California San Francisco (UCSF), San Francisco, United States
Dr. Angela Lamarca
Consultant in Medical Oncology, Fundación Jiménez Díaz, Madrid, Spain